These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3140476)

  • 41. Prognostic prediction of BRAF(V600E) and its relationship with sodium iodide symporter in classic variant of papillary thyroid carcinomas.
    Gao WL; Wie LL; Chao YG; Wie L; Song TL
    Clin Lab; 2012; 58(9-10):919-26. PubMed ID: 23163107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Measurement of cellular DNA content in thyroid tumors by the flow cytometer].
    Motomura Y
    Nihon Geka Gakkai Zasshi; 1988 Jul; 89(7):1066-74. PubMed ID: 3221827
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic scoring systems in differentiated thyroid carcinoma: which is the best?
    Kingma G; van den Bergen HA; de Vries JE
    Neth J Surg; 1991 Jun; 43(3):63-6. PubMed ID: 1922882
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAF(K601E) Mutation.
    Afkhami M; Karunamurthy A; Chiosea S; Nikiforova MN; Seethala R; Nikiforov YE; Coyne C
    Thyroid; 2016 Feb; 26(2):242-7. PubMed ID: 26422023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of nuclear DNA analysis in histological sections in mammary carcinoma.
    Erhardt K; Auer G; Fallenius A; Folin A; Forsslund G; Silfverswärd C; Zetterberg A
    Am J Clin Oncol; 1986 Apr; 9(2):117-25. PubMed ID: 3012992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nuclear DNA content of the tall cell variant of papillary carcinoma of the thyroid gland.
    Stern Y; Medelia O; Feinmesser M; Shpitzer T; Feinmesser R; Segal K
    Ann Otol Rhinol Laryngol; 1996 Sep; 105(9):713-5. PubMed ID: 8800058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statistical evaluation of the prognostic value of nuclear DNA content in papillary, follicular, and medullary thyroid tumors.
    Bäckdahl M; Carstensen J; Auer G; Tallroth E
    World J Surg; 1986 Dec; 10(6):974-80. PubMed ID: 3798947
    [No Abstract]   [Full Text] [Related]  

  • 48. Fine-needle biopsy cytology and DNA analysis. Their place in the evaluation and treatment of patients with thyroid neoplasms.
    Bäckdahl M; Wallin G; Löwhagen T; Auer G; Granberg PO
    Surg Clin North Am; 1987 Apr; 67(2):197-211. PubMed ID: 3551144
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases.
    Woodford RL; Nikiforov YE; Hunt JL; Bellizzi AM; Zhang X; Mills SE; Stelow EB
    Am J Surg Pathol; 2010 Nov; 34(11):1582-90. PubMed ID: 20924280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of nuclear DNA content in papillary and follicular thyroid cancer.
    Hamming JF; Schelfhout LJ; Cornelisse CJ; van de Velde CJ; Goslings BM; Hermans J; Fleuren GJ
    World J Surg; 1988 Aug; 12(4):503-8. PubMed ID: 3420932
    [No Abstract]   [Full Text] [Related]  

  • 51. Retrospective DNa analysis of T3/T4 breast carcinoma using cytophotometry and flow cytometry. A comparative study with prognostic evaluation.
    Roos G; Arnerlöv C; Emdin S
    Anal Quant Cytol Histol; 1988 Jun; 10(3):189-94. PubMed ID: 3408544
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression.
    Batista FA; Ward LS; Marcello MA; Martins MB; Peres KC; Torricelli C; Bufalo NE; Soares FA; da Silva MJ; Assumpção LV
    J Endocrinol Invest; 2016 Apr; 39(4):423-9. PubMed ID: 26370671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of nuclear DNA content in follicular thyroid tumours.
    Bäckdahl M; Auer G; Forsslund G; Granberg PO; Hamberger B; Lundell G; Löwhagen T; Zetterberg A
    Acta Chir Scand; 1986 Jan; 152():1-7. PubMed ID: 3953203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic value of preoperative DNA measurement on FNA in benign and malignant thyroid neoplasm.
    Perigli G; Cicchi P; Cianchi F; Artusi R; Olivari D; Caldini A; Cortesini C
    J Exp Clin Cancer Res; 1998 Mar; 17(1):113-6. PubMed ID: 9646245
    [No Abstract]   [Full Text] [Related]  

  • 55. The thyroid nodule. Diagnosis and surgical treatment.
    Lennquist S
    Surg Clin North Am; 1987 Apr; 67(2):213-32. PubMed ID: 3551145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single cell DNA cytophotometry in clinical stage I malignant melanoma. Relationship to prognosis.
    Lindholm C; Hofer PA; Jonsson H
    Acta Oncol; 1990; 29(2):147-50. PubMed ID: 2334568
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unusual tumors of the thyroid gland.
    Baloch ZW; LiVolsi VA
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):297-310, vii. PubMed ID: 18502328
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Thyroid carcinoma].
    Namba H; Izumi M
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):22-9. PubMed ID: 1987898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNA aneuploidy in G1-urothelial carcinomas of the urinary bladder.
    Borchers H; Planz B; Jakse G; Böcking A
    Urol Int; 1994; 52(3):145-50. PubMed ID: 8203053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is agNOR and DNA ploidy analysis useful for evaluating thyroid neoplasms?
    Camargo RS; Maeda MY; di Loreto C; Shirata NK; Anselmo Garcia E; Filho AL
    Anal Quant Cytol Histol; 2005 Jun; 27(3):157-61. PubMed ID: 16121637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.